Rothschild upgrades Kenvue after Tylenol scare wipes $10 billion in market value

Investing.comFriday, September 26, 2025 at 12:36:53 PM
Rothschild has upgraded its rating for Kenvue following a significant market scare that saw Tylenol's parent company lose $10 billion in value. This upgrade is crucial as it reflects confidence in Kenvue's resilience and potential for recovery, especially after the recent turmoil. Investors are likely to view this positively, as it suggests that Kenvue is well-positioned to navigate challenges and capitalize on future opportunities.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
UBS upgrades Tabcorp stock to Buy on strategic progress and earnings outlook
PositiveFinancial Markets
UBS has upgraded Tabcorp's stock to a 'Buy' rating, highlighting the company's strategic progress and promising earnings outlook. This upgrade is significant as it reflects investor confidence in Tabcorp's ability to navigate challenges and capitalize on growth opportunities, potentially leading to increased investor interest and stock performance.
RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next?
NegativeFinancial Markets
RFK Jr. is making headlines again, this time targeting vaccines and Tylenol, claiming that the latter could be linked to autism. These unsupported allegations have left Kenvue, the maker of Tylenol, in a difficult position. As Kennedy continues to challenge established medical products, it raises concerns about public perception and trust in vaccines and medications. This situation is significant as it could influence health decisions and policies, potentially impacting many lives.
‘Supercycle’ May Prolong $100 Billion Rally in Korean Chipmakers
PositiveFinancial Markets
The recent surge in market value, exceeding $100 billion for South Korea's leading chipmakers, is expected to continue as the artificial intelligence boom expands into various sectors of technology. This rally is significant as it highlights the growing importance of AI in driving market trends and the potential for sustained growth in the tech industry.
Trump told pregnant women to ‘tough it out’ instead of take Tylenol. A study of 2.5 million births in Sweden finds zero evidence to back him up
NegativeFinancial Markets
A recent study analyzing 2.5 million births in Sweden has found no evidence supporting former President Trump's suggestion that pregnant women should avoid taking Tylenol. This research, which tracked children born between 1995 and 2019, highlights the importance of evidence-based medicine, especially when it comes to the health of mothers and their babies. The findings challenge Trump's controversial stance and emphasize the need for reliable information in healthcare decisions.
Doctors dismiss Trump’s warnings, reassure pregnant women Tylenol is OK if needed
PositiveFinancial Markets
In a reassuring response to recent comments made by Donald Trump regarding the safety of Tylenol for pregnant women, medical professionals have clarified that the medication is indeed safe to use when necessary. This is important as it alleviates concerns among expectant mothers who may be worried about the implications of taking medication during pregnancy. The doctors emphasize that Tylenol can be an effective option for managing pain and fever, ensuring that women can maintain their health without unnecessary anxiety.
Freeport-McMoRan stock upgraded by Bernstein as Grasberg mine impact assessed
PositiveFinancial Markets
Freeport-McMoRan's stock has received an upgrade from Bernstein, reflecting a positive assessment of the Grasberg mine's impact on the company's future. This upgrade is significant as it indicates investor confidence in Freeport's operations and potential growth, especially given the importance of the Grasberg mine in their portfolio. Such endorsements can lead to increased investor interest and potentially higher stock prices, making it a noteworthy development in the mining sector.
The truth behind Trump's claims about autism and paracetamol, or Tylenol – video
NegativeFinancial Markets
Donald Trump's recent claims linking autism to the use of common painkillers like paracetamol, also known as Tylenol, have been widely dismissed by global health agencies and regulators as unscientific. This misinformation not only undermines public trust in health guidelines but also poses risks to public health by spreading fear and confusion about safe medications. Understanding the facts is crucial, as it helps to combat the spread of false information and ensures that people make informed choices regarding their health.
Thune Becomes Highest-Ranking Republican To Cast Doubt On Trump’s Claims About Tylenol And Autism
NeutralFinancial Markets
Senator John Thune has become the highest-ranking Republican to express skepticism about former President Trump's claims linking Tylenol to autism. Thune emphasized the importance of relying on scientific evidence when discussing health-related issues. This statement is significant as it highlights a potential shift in the Republican Party's stance on public health discussions, encouraging a more evidence-based approach.
Tylenol-maker Kenvue shares bounce back, Trump claims face pushback
PositiveFinancial Markets
Kenvue, the maker of Tylenol, has seen a significant rebound in its shares, reflecting investor confidence in the company's future. This positive trend comes amid various market challenges and highlights the resilience of Kenvue's product line. Meanwhile, former President Trump is facing pushback on his recent claims, which adds an interesting layer to the current business landscape. The performance of Kenvue's shares is crucial as it indicates the health of the pharmaceutical sector and consumer trust in established brands.
Trump links autism to Tylenol and vaccines, claims not backed by science
NegativeFinancial Markets
Former President Donald Trump has stirred controversy by linking autism to the use of Tylenol and vaccines, a claim that lacks scientific backing. This assertion raises concerns as it may contribute to misinformation about autism and vaccine safety, potentially influencing public perception and health decisions. It's crucial to rely on credible scientific research when discussing such sensitive topics.
Latest from Financial Markets
Opinion | CNN and Comey
NeutralFinancial Markets
The article discusses the relationship between CNN and former FBI Director James Comey, highlighting the network's insider source related to ongoing stories. This connection is significant as it sheds light on how media outlets gather information and the implications of having sources close to high-profile figures, which can influence public perception and trust in journalism.
Newamsterdam Pharma stock hits 52-week high at 27.4 USD
PositiveFinancial Markets
Newamsterdam Pharma's stock has reached a 52-week high of 27.4 USD, reflecting strong investor confidence and positive market trends. This milestone is significant as it indicates the company's growth potential and could attract more investors, boosting its market presence.
Bank of England's Dhingra calls for faster interest rate cuts
PositiveFinancial Markets
The Bank of England's Dhingra has advocated for quicker interest rate cuts, suggesting that a more aggressive approach could stimulate economic growth. This is significant as it reflects a shift in monetary policy that could ease borrowing costs for consumers and businesses, potentially leading to increased spending and investment. As the economy faces challenges, Dhingra's call for action may provide a much-needed boost.
Argentina’s President Vowed to Fix Its Economy. Then Came a Crisis.
NegativeFinancial Markets
Argentina's President has pledged to address the country's economic challenges, but recent events have led to a significant crisis that threatens these efforts. This situation is crucial as it not only impacts the nation's financial stability but also affects the daily lives of its citizens, highlighting the urgent need for effective leadership and solutions.
Amazon is selling a top-rated 3-piece luggage set for only $70, and 'the quality is excellent'
PositiveFinancial Markets
Amazon has a fantastic deal on a highly-rated 3-piece luggage set for just $70, and customers are raving about its excellent quality. This is a great opportunity for travelers looking for reliable and affordable luggage options, especially for those who frequently take trips. With the ability to manage a 15-day journey using just the carry-on and personal bag, this set proves to be both practical and stylish, making it a must-have for anyone on the go.
Trump’s energy pivot accelerates US solar and wind power mergers, asset sales
PositiveFinancial Markets
Trump's recent energy pivot is driving a surge in mergers and asset sales within the US solar and wind power sectors. This shift not only reflects a growing commitment to renewable energy but also presents significant opportunities for investment and innovation in these industries. As companies adapt to the changing landscape, the potential for job creation and environmental benefits increases, making this a pivotal moment for the future of energy in the United States.